Radical S-adenosyl-l-methionine
(RS)
enzymes operate on a variety of substrates and catalyze a wide range
of complex radical-mediated transformations. Radical non-α-carbon
thioether peptides (ranthipeptides) are a class of ribosomally synthesized
and post-translationally modified peptides (RiPPs). The RS enzyme
PapB catalyzes the formation of thioether cross-links between Cys/Asp
(or Cys/Glu) residues located in six Cys-X3-Asp/Glu motifs.
In this report, using a minimal substrate that contains a single cross-link
motif, we explore the substrate scope of the PapB and show that the
enzyme is highly promiscuous and will accept a variety of Cys-X
n
-Asp sequences where n =
0–6. Moreover, we show that the enzyme will introduce in-line
and nested thioether cross-links independently in peptide sequences
that contain two motifs derived from the wild-type sequence. Additionally,
the enzyme accepts peptides that contain d-amino acids at
either the Cys or the Asp position. These observations are leveraged
to produce a thioether cyclized analogue of the FDA-approved therapeutic
agent octreotide, with a Cys-Glu cross-link replacing the disulfide
that is found in the drug. These findings highlight the remarkable
substrate tolerance of PapB and show the utility of RS RiPP maturases
in biotechnological applications.